Ginkgo Bioworks Holdings, Inc.
Could not find a ticker for this position, may be a filing error
A maker of cell-engineering tools, Ginkgo Bioworks designs custom organisms and cells for pharmaceutical, agricultural, and industrial clients, using lab automation and AI models. Its Canopy and Horizon biosecurity platforms monitor wastewater and other samples for government customers to spot emerging biological threats. Founded in 2008 by five MIT scientists who wanted to make biology easier to engineer, the company took its name from the ginkgo tree, an ancient "living fossil" unchanged for tens of millions of years.
Warrant (expires 08/01/202)
Granted 8.08M · Sold 2.16M
Granted 53.42M · Sold 28.51M
Granted 53.42M · Sold 28.51M
Granted 176.2K
Granted 26.98M · Sold 22.87M
Granted 187.0K · Bought 647.6K
Granted 338.9K · Sold 155.9K
Granted 186.0K
Granted 1.45M · Bought 1.02M
Granted 2.55M · Sold 1.45M
Granted 477.5K · Sold 224.6K
Granted 1.49M · Sold 162.5K
Granted 24.1K
Granted 173.1K
Granted 10.8K
Granted 10.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Halvorsen Ole Andreas +7 co-filers10% owner · 1 transaction | — | 339.06Mas of Mar 2022 | — | — | — |
| Eagle Equity Partners III, LLCDirector · 1 transaction | — | 31.59Mas of Sep 2021 | — | — | — |
| Dekkers Marijn EDirector · 8 transactions | — | 5.90Mas of Jun 2024 | 8.08M | — | 2.16M |
| Canton Barry10% owner · 264 transactions | — | 775.0K | 53.42M | — | 28.51M |
| Shetty Reshma P.See remarks, Director, 10% owner · 264 transactions | — | 775.0K | 53.42M | — | 28.51M |
| Belldegrun ArieDirector · 2 transactions | — | 694.9Kas of Jun 2024 | 176.2K | — | — |
| Kelly Jason RSee remarks, Director · 183 transactions | — | 316.5K | 26.98M | — | 22.87M |
| Sloan HarryDirector · 7 transactions | — | 271.4Kas of Jun 2025 | 187.0K | 647.6K | — |
| Fallon Marie E.See remarks · 27 transactions | — | 233.6Kas of May 2023 | 338.9K | — | 155.9K |
| Kewalramani ReshmaDirector · 3 transactions | — | 186.0Kas of Jun 2024 | 186.0K | — | — |
| Sankar ShyamDirector · 7 transactions | — | 72.4Kas of Jun 2025 | 1.45M | 1.02M | — |
| Dmytruk Mark E.See remarks · 138 transactions | — | 52.1Kas of May 2025 | 2.55M | — | 1.45M |
| Coen Steven P.See remarks · 71 transactions | — | 50.7K | 477.5K | — | 224.6K |
| Henry Christian ODirector · 21 transactions | — | 24.3K | 1.49M | — | 162.5K |
| Kosuri SriDirector · 1 transaction | — | 24.1Kas of Jun 2025 | 24.1K | — | — |
| Hannan Kathy HopinkahDirector · 3 transactions | — | 15.0Kas of Jun 2025 | 173.1K | — | — |
| Fubini RossDirector · 1 transaction | — | 10.8Kas of Jun 2025 | 10.8K | — | — |
| Potter Myrtle SDirector · 1 transaction | — | 10.8Kas of Jun 2025 | 10.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -82.38M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.